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ertebrate oocytes arrest in the second metaphase of
meiosis (metaphase II [MII]) by an activity called
cytostatic factor (CSF), with aligned chromosomes
and stable spindles. Segregation of chromosomes occurs
after fertilization. The Mos/…/MAPK (mitogen-activated
protein kinases) pathway mediates this MII arrest. Using a
two-hybrid screen, we identiﬁed a new MAPK partner from
a mouse oocyte cDNA library. This protein is unstable
during the ﬁrst meiotic division and accumulates only in
MII, where it localizes to the spindle. It is a substrate of the
Mos/…/MAPK pathway. The depletion of endogenous RNA
V
 
coding for this protein by three different means (antisense
RNA, double-stranded [ds] RNA, or morpholino oligo-
nucleotides) induces severe spindle defects speciﬁc to
MII oocytes. Overexpressing the protein from an RNA not
targeted by the morpholino rescues spindle destabilization.
However, dsRNA has no effect on the ﬁrst two mitotic
divisions. We therefore have discovered a new MAPK
substrate involved in maintaining spindle integrity during
the CSF arrest of mouse oocytes, called MISS (for MAP
kinase–interacting and spindle-stabilizing protein).
 
Introduction
 
Meiotic maturation in vertebrate oocytes corresponds to the
period including the exit from the G2 block to the arrest in
metaphase of the second meiotic division (metaphase II
[MII]*). Meiotic maturation starts with the activation of
maturation-promoting factor (MPF), which triggers germinal
vesicle breakdown (GVBD), chromosome condensation,
and formation of the first meiotic spindle. This spindle
migrates to the cortex and after extrusion of the first polar
body, the second meiotic spindle forms below the cortex,
where it remains stable for hours with chromosomes aligned
on the metaphase plate.
The cascade initiated by c-mos, which activates mitogen-
activated protein kinases (MAPK) (the Mos/…/MAPK
pathway), controls many important events of meiotic
maturation (for an extensive review see Abrieu et al., 2001).
This pathway controls the migration of the germinal vesicle
(GV) to the cortex in 
 
Xenopus
 
 oocytes and the migration of
the first meiotic spindle to the cortex in mouse oocytes (Choi
et al., 1996; Gavin et al., 1999; Verlhac et al., 2000a). It is
therefore essential for the establishment of asymmetric divisions
during meiosis. This pathway also controls microtubule
organization in mouse oocytes (Verlhac et al., 1994,
1996). Moreover, the Mos/…/MAPK pathway promotes
the cytostatic factor (CSF; Masui and Markert, 1971) arrest
of vertebrate oocytes (Haccard et al., 1993; Colledge et al.,
1994; Hashimoto et al., 1994; Verlhac et al., 1996). Indeed,
vertebrate oocytes are arrested at metaphase of the second
meiosis by an egg cytoplasmic substance called CSF. Then
fertilization will release the egg from the arrest and allow it
to complete meiosis and proceed to mitosis. The CSF arrest
of the cell cycle is affected by the Mos/…/MAPK cascade,
which results in the activation of the ribosomal S6 kinase
p90
 
rsk
 
 (Bhatt and Ferrell, 1999; Gross et al., 1999, 2000).
However, the mechanism of the cell cycle arrest in MII has not
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been fully clarified. Particularly puzzling is the fact that the cell
cycle is not arrested at metaphase I (MI), whereas all the ki-
nases mentioned above have already been activated before MI.
So molecules activated only in MII and targets of the Mos/…/
MAPK pathway could also be involved in the CSF arrest.
To look for physiological effectors of the Mos/…/MAPK
pathway in meiosis, we generated a mouse immature oocyte
cDNA library that we screened by two hybrid using MAPK as
a bait. We isolated a new protein, MAP kinase–interacting
and spindle-stabilizing protein (MISS), which is rich in pro-
line residues and has four potential MAPK phosphorylation
sites, a MAPK docking site, a PEST sequence, and a bipartite
nuclear localization signal (NLS). Apart from a potential hu-
man homologue, we did not find any homologies with other
proteins in the databases. In mouse oocytes, MISS is a poten-
tial in vivo substrate for the Mos/…/MAPK pathway. The en-
dogenous protein accumulates during mouse meiotic matura-
tion and localizes as discrete dots on the MII spindle. Also, a
MISS–GFP construct localizes to kinetochore microtubules in
MII oocytes. The stability of MISS is regulated during mouse
meiotic maturation. It is unstable in MI, where its degrada-
tion is microtubule dependent, and becomes stable in MII.
MISS is again unstable after parthenogenetic activation and
the endogenous protein is no longer detected in early em-
bryos. By microinjecting both antisense (as) RNA, double-
stranded (ds) RNA, and morpholino oligonucleotides (Sum-
merton and Weller, 1997) directed against MISS endogenous
mRNA, we show that it is involved in maintaining MII spin-
dle integrity. Mouse oocytes microinjected with any of these
three different molecules, and not control molecules, display
disorganized MII spindles and numerous asters in their cyto-
plasm. Moreover, the spindle defects induced after microin-
jection of morpholino oligonucleotides directed against 25 bp
upstream of the ATG can be rescued by the overexpression of
Myc–MISS from RNA corresponding to the full-length ORF
devoid of MISS 5
 
 
 
 UTR. The injection of dsRNA against
MISS has yet no effect on the first two mitotic divisions, sug-
gesting a specific role for MISS in meiosis. MISS is the first
example of a physiological MAPK substrate that is stabilized
in MII and specifically regulates MII spindle integrity during
the CSF arrest.
 
Results
 
Isolation of MISS that binds ERK2
 
We have prepared a two-hybrid cDNA library from 1,000
mouse immature oocytes. This library was screened using rat
extracellular regulated kinase 2 (ERK2, one of the two mam-
malian MAPK) as a bait. From this screen, six clones were
isolated that encoded a partial cDNA of 
 
 
 
500 bp. We con-
firmed the specificity of the two-hybrid interaction between
this partial cDNA product and ERK2 (Fig. 1 A).
A mouse EST showing 95 overlapping base pairs with our
partial cDNA enabled us to obtain the full-length ORF
from the databases (Fig. 2 A). A full-length clone, identi-
cal to ours, has recently been pulled out from an mCAP-
enriched cDNA library (Kawai et al., 2001). The sequence of
the MISS mRNA and protein is presented in Fig. 2 B. This
protein is very rich in proline residues in its NH
 
2
 
-terminal
end and harbors a PEST sequence, a bipartite NLS that con-
tains a MAPK docking site (Tanoue et al., 2000), and po-
tential MAPK phosphorylation sites (Fig. 2 C).
We confirmed the two-hybrid interaction by showing that
MISS coimmunoprecipitates with endogenous MAPK from
 
Xenopus
 
 oocyte extracts (Fig. 1 B).
 
MISS mRNA is present in immature oocytes but MISS 
protein accumulates after meiosis resumption and 
localizes to the MII spindle
 
To check if the full-length RNA encoding MISS was present
in mouse oocytes, we performed RT-PCR using primers spe-
cific for the MISS mRNA. By RT-PCR, we could amplify a
Figure 1. Interaction between MISS and MAPK. (A) Two-hybrid 
interaction between MISS and MAPK. MISS interacts with ERK2WT 
and ERK2KD but not with a negative control. The yeast transformed 
with LexA-ERK2WT, LexA-ERK2KD (Waskiewicz et al., 1997), 
LexA-53 (positive control; CLONTECH Laboratories, Inc.), 
LexA-Su(Fu), or LexA alone were mated with yeast transformed 
respectively with B42-cDNA, B42-AD-T (positive control; CLONTECH 
Laboratories, Inc.), or empty B42. The diploids obtained were 
assayed for transactivation of both the  -galactosidase and the LEU2 
reporter genes on glucose (Glu)- or galactose (Gal/Raf)-containing 
mediums. The B42 fusion proteins are under the control of the 
galactose promoter. The B42-cDNA clearly interacts both with 
fusions of ERK2WT and ERK2KD at levels identical to the positive 
control, whereas it does not interact with a negative control (Su[Fu]). 
(B) MISS coimmunoprecipitates with endogenous p42
mpk from 
Xenopus oocyte extracts. Oocyte extracts expressing Myc–Wnt11 
(Xenopus Wint11; negative control) or Myc–MISS RNA (lanes 1 and 
2). Anti-p42
mpk1 immunoprecipitates (lanes 3 and 4) prepared from 
the oocyte lysates were analyzed by immunoblotting with anti-Myc 
antibody. This experiment was performed three times. (C) Expression 
of MISS RNA in immature oocytes and two cell stage embryos. For 
RT-PCR analysis, total RNA was isolated from mouse ovaries (lane 2), 
immature oocytes (lanes 3 and 4), and two cell stage embryos (lanes 
5 and 6) and treated with or without reverse transcriptase (RT,   or  ). 
Lane 1 corresponds to a PCR control (water). (D) MISS accumulates 
during meiotic maturation. 2,000 immature (lane 1) or mature (lane 
2) oocytes were collected and immunoblotted using an affinity-purified 
anti-MISS antibody. 
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specific band of 
 
 
 
800 bp corresponding to the full-length
MISS ORF (Fig. 1 C). As shown in Fig. 1 C, MISS mRNA is
expressed in mouse ovaries, mouse immature oocytes (at the
GV stage), and two cell stage mouse embryos. However, both
by immunoblotting (Fig. 1 D, lane 1) and immunofluores-
cence (Fig. 3 A) using an affinity-purified anti-MISS peptide
antibody, we could not detect the presence of the endogenous
protein in immature oocytes. MISS was present in mature oo-
cytes (Fig. 1 D, lane 2). The apparent molecular weight being
around 45 kD suggests that MISS undergoes posttranslational
modifications. By immunofluorescence, MISS was undetect-
able in GV oocytes (Fig. 3 A), was hardly detectable in the vi-
cinity of the chromosomes in late MI oocytes (Fig. 3 B), and
accumulated strongly and became localized in MII-arrested
oocytes (Fig. 3, C and D). Both the cytoplasmic and the MII
spindle staining are specific because they are no longer present
when the purified antibody is preincubated with the immuno-
genic peptide (Fig. 3 F). Interestingly, we could not detect any
staining in early mouse embryos (Fig. 3 E), suggesting that
MISS accumulates specifically in meiosis. A MISS–GFP con-
struct also behaves like the endogenous protein during mei-
 
otic maturation. Indeed, the overexpressed MISS–GFP pro-
tein is detected by immunoblotting in MII oocytes (Fig. 4 F),
and no localization of the MISS–GFP protein is detected in
MI oocytes (Fig. 4 A). In MII oocytes, the MISS–GFP local-
izes in patches along fibers that evoke kinetochore fibers ema-
nating from the chromosomes (Fig. 4, B, F, and G).
 
 
 
The
MISS–GFP protein also localizes along the spindle in mitotic
dividing embryos (Fig. 4 D). After activation and in inter-
phase, the MISS–GFP protein is completely excluded from
the cytoplasm and present only in the nucleus, where small
dots are observed (Fig. 4, C and E). This result suggests that
the NLS present in the protein is functional and involved in a
tight regulation of MISS localization.
 
MISS is unstable in MI and stable in MII
 
Our anti-MISS antibody was not very sensitive by immuno-
blotting, as it required 2,000 MII oocytes (one mouse gives
Figure 2. The sequence of MISS. (A) Schematic representation of 
how the full-length ORF was isolated. (B) Nucleotide and amino 
acid sequence of MISS ORF (GenBank/EMBL/DDBJ accession no. 
AK009250). The amino acid sequence is rich in proline in the 
NH2-terminal end and contains a PEST sequence, a bipartite NLS 
and four potential MAPK phosphorylation sites. The MAPK docking 
site is boxed. (C) Schematic representation of the full-length MISS 
protein indicating the different domains.
Figure 3. Immunofluorescent staining of MISS in oocytes and 
early embryos. Groups of 20–30 oocytes at different stages of meiotic 
maturation were fixed with formaldehyde and further stained with 
an affinity-purified anti-MISS antibody. All oocytes were analyzed 
by confocal microscopy using identical settings. (A) Immature 
oocytes (GV). (B) MI oocyte. (C and D) MII oocyte. (E) Two cell 
stage embryo. (F) MII oocyte stained with the affinity-purified anti-
body preincubated with 30 mM of the immunogenic peptide. This 
experiment was repeated three times. The MISS staining appears in 
green and chromosomes in red. Bar, 10  m. 
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40 oocytes). To analyze more easily the behavior of MISS
during mouse meiotic maturation, we microinjected Myc–
MISS RNA into mouse immature oocytes and followed the
tagged protein during meiotic maturation.
First we checked that the Myc–MISS behaves like the en-
dogenous MISS. Indeed, the exogenous protein could not be
detected in immature oocytes, whereas it was present in ma-
ture oocytes (Fig. 5 A, lanes 1 and 2). We microinjected chi-
meric RNA that contained the MISS ORF flanked by the 5
 
 
 
and 3
 
 
 
 UTR of the 
 
Xenopus
 
 
 
 
 
-globin gene, thus the transla-
tion of the Myc–MISS encoding RNA was not submitted to
translational regulations by MISS endogenous 5
 
 
 
 and 3
 
 
 
UTR. Using the same construct, we typically observed similar
amounts of translation of the exogenous RNA both in imma-
ture and mature oocytes when allowed to overexpress for the
same amount of time (Fig. 5 A; the levels of expression of
Myc–ERK2 are similar in immature and mature oocytes).
Then, we injected a pool of GV oocytes with RNA coding
for Myc–MISS and cultured them for the same total amount
of time (14 h). We collected them at different stages after
meiosis resumption: early MI (2–6 h after GVBD); late MI
(8 h after GVBD); or MII (12 h after GVBD). This kind of
experiment is possible in mouse oocytes by releasing oocytes
after a different length of time spent in medium supple-
mented with dbcAMP. Meiosis resumption of mouse oo-
cytes occurs spontaneously by removing the oocytes from
the ovaries. However, they can be maintained at the GV
stage by keeping them in a dbcAMP-containing medium
(the dbcAMP mimics a high concentration of AMPc, which
has an inhibitory effect on meiosis resumption). In this way,
each sample belongs to a pool of oocytes that were injected
at the same time and that had expressed the protein for the
same amount of time. We could not detect Myc–MISS pro-
tein in early MI oocytes (Fig. 5 B). Myc–MISS accumulates
only late during meiotic maturation, around the first polar
body extrusion (Fig. 5 B). It suggests that the protein is un-
stable in MI. We show here that Myc–MISS accumulates
rapidly around the first polar body extrusion.
Because the kinetics of Myc–MISS accumulation are simi-
lar in wild-type compared with mos
 
 
 
/
 
 
 
 oocytes (Fig. 5 C),
which do not have MAPK activity (Verlhac et al., 1996), the
Mos/…/MAPK pathway does not regulate MISS stability.
To demonstrate that Myc–MISS is indeed unstable in MI
due to a high turnover of the protein, we examined its stabil-
ity in oocytes incubated in nocodazole. In mouse oocytes,
cyclin B1 is stabilized by nocodazole treatment, suggesting
that its degradation requires intact microtubules (Kubiak et
al., 1993). We treated Myc–MISS-injected oocytes with no-
codazole for 3 h. As shown in Fig. 5 D, this treatment in-
duces Myc–MISS and cyclin B1 accumulation before polar
body extrusion. This shows that MISS is unstable in MI and
is degraded by a microtubule-dependent mechanism.
To analyze MISS behavior after parthenogenetic activation,
we microinjected Myc–MISS RNA into MII-arrested oocytes.
Half of the injected oocytes were activated by ethanol treat-
ment, whereas the other half was not treated. As shown in Fig.
5 E, Myc–MISS accumulates during the MII arrest (lanes 3
and 4), whereas it is unstable after activation (lanes 1 and 2).
Figure 4. MISS–GFP in mouse oocytes 
and embryos. Overexpression of MISS–
GFP protein after microinjection of RNA 
coding MISS–GFP into wild-type oocytes, 
zygotes, and one blastomere of a late two 
cell stage embryo. Oocytes, zygotes, and 
embryos were fixed at the indicated 
stages and analyzed by confocal 
microscopy. For A–E, the projection of 
all confocal sections was performed. 
(A) Oocyte collected in MI. (B) Oocyte 
collected in MII. (C) Zygote with male 
and female pronuclei. (D) Two cell 
embryo injected into one blastomere 
that is in mitosis (M). (E) Eight cell 
embryo in interphase (I). (F) Oocyte 
collected in MII (only one confocal 
section). (G) Higher magnification of 
the chromatin area from the oocyte in 
D. Experiments have been repeated 
three times. The MISS–GFP staining 
appears in green and chromosomes in 
red. Bar, 10  m. (H) 20 injected oocytes 
collected 6 h (lane 1) and 12 h after 
GVBD (lane 2) were analyzed by 
immunoblotting using an anti-GFP 
antibody. 
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As we observed by immunofluorescence on the endoge-
nous protein, Myc–MISS protein accumulated late in MI.
Based on the nocodazole experiment and the behavior of
other Myc-tagged proteins in mouse oocytes (i.e., Myc–
ERK2; Fig. 5 A; Verlhac et al., 2000b), we conclude that
MISS is stabilized only during the MII stage.
 
Myc–MISS is a substrate of the Mos/…/MAPK pathway
 
The protein sequence of MISS displays four potential ERK
phosphorylation sites and a MAPK docking site. We have
 
shown that active MAPK can phosphorylate MISS in vitro
(unpublished data). To determine whether the protein is an in
vivo substrate of MAPK, we checked for its electrophoretic
mobility in oocytes from mos
 
 
 
/
 
 
 
 oocytes. In these oocytes, the
migration of Myc–MISS is faster compared with its electro-
phoretic mobility in wild-type oocytes, reflecting a posttrans-
lational modification of Myc–MISS in wild-type oocytes (Fig.
6 A). Among the posttranslational modifications, we show
that at least some of them are associated with phosphoryla-
tion. Indeed, treatment of the protein isolated from MII-
arrested oocytes with 
 
 
 
-phosphatase induced a downshift of
its electrophoretic mobility (Fig. 6 B, compare lanes 1 and 2).
Moreover, the migration of Myc–MISS in 2D gel electro-
phoresis is shifted to the acidic pole (H
 
 
 
) in wild-type oocytes
compared with its migration in mos
 
 
 
/
 
 
 
 oocytes (Fig. 6 C). Be-
cause phosphorylations are associated with negative charges,
this result suggests that the protein is more phosphorylated in
wild-type oocytes compared with mos
 
 
 
/
 
 
 
 oocytes.
Figure 5. MISS is unstable in MI and activated oocytes and stable 
in MII oocytes. For A–D, a pool of immature oocytes was injected 
with RNA and cultured for 14 h. Each sample corresponds to a pool 
of 20–40 oocytes from the same injection and to oocytes that have 
expressed the protein for the same amount of time (14 h). Experiments 
have been repeated three to four times. (A) Overexpression of Myc–
MISS protein (top) or Myc–ERK2 (bottom) after microinjection of the 
corresponding RNA into wild-type immature oocytes. 20 oocytes 
were collected as immature (lane 1) or mature (12 h after GVBD; lane 
2). (B) Myc–MISS-injected wild-type oocytes were collected 2 h (lane 
1), 4 h (lane 2), 6 h (lane 3), 8 h (before polar body extrusion; lane 4), 
8 h (after polar body extrusion; lane 5), or 12 h (lane 6) after GVBD. 
(C) Myc–MISS-injected mos
 /  oocytes were collected 4 h (lane 1), 6 h 
(lane 2), 8 h (before polar body extrusion; lane 3), or 12 h (lane 4) 
after GVBD. (D) Myc–MISS-injected wild-type oocytes were collected 
5 h (lane 1), 6.5 h (lane 2), 8 h (before polar body extrusion; lane 3), 
or 12 h (lane 5) after GVBD. Oocytes microinjected with Myc–MISS 
were also cultured for 5 h after GVBD, incubated for 3 h in nocodazole 
(NZ; 10  M), and collected (lane 4). The top panel is the anti-Myc 
immunoblot, and the bottom panel is the anti-cyclin B1 immunoblot. 
(E) Myc–MISS-injected wild-type oocytes were activated by ethanol 
treatment (lanes 1 and 2) or not (lanes 3 and 4) and further cultured 
for 1 or 6 h. All samples, except bottom blot in D, were analyzed by 
immunoblotting using an anti-Myc antibody.
Figure 6. Myc-MISS is a substrate of the Mos/…/MAPK pathway. 
(A) Myc–MISS-injected oocytes from wild-type (lane 1) or mos
 /  
(lane 2) mice were cultured for 14 h after GVBD and then collected. 
In the mos
 /  oocytes (lane 2), the electrophoretic migration of 
Myc–MISS is faster compared with its mobility in wild-type oocytes 
(lane 1). (B) In vitro dephosphorylation of Myc–MISS in oocyte 
extracts. 30 oocytes were injected with RNA encoding Myc–MISS, 
cultured 14 h after GVBD, collected in water, and incubated 
without (lane 1) or with 400 U of  -phosphatase (lane 2). 
(C) Overexpression of Myc–MISS protein after microinjection of 
RNA encoding Myc–MISS into immature wild-type or mos
 /  
oocytes. 40 oocytes were collected 14 h after GVBD and were 
analyzed by 2D gel electrophoresis. The migration of Myc–MISS 
shifts toward the acidic pole (H
 ) in wild-type oocytes, compared 
with its migration in mos
 /  oocytes. We have used an internal 
control to compare the position of dots (Louvet-Vallee et al., 2001). 
Experiments have been repeated three times. All samples were 
analyzed by immunoblotting using an anti-Myc antibody. 
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Altogether our results show that Myc–MISS is an in vivo
substrate of the Mos/…/MAPK pathway.
 
Interfering with endogenous MISS mRNA induces 
severe spindle defects in MII-arrested oocytes
 
To determine the potential role of MISS during mouse meiotic
maturation, we decided to interfere with endogenous mRNA
expression. Three different types of molecules were used. First,
asRNA (asMISS) or dsRNA (dsMISS) directed against the full-
length ORF were microinjected into immature oocytes. The
microinjection of either asRNA or dsRNA directed against en-
dogenous MISS mRNA had no effect on GVBD or first polar
body extrusion (data not shown). However, both injections in-
duced severe spindle disorganization in MII-arrested oocytes.
As shown in Fig. 7, B and D, the MII spindle loses its bipolarity
and numerous asters appear in the cytoplasm. This phenotype
is visible right after the MII spindle is formed (13 h after
GVBD). It is never observed in noninjected oocytes or in oo-
cytes injected with an irrelevant dsRNA at the same concentra-
tion and directed against 
 
Xenopus
 
 frizzled 7 (Fig. 7, A and C).
As expected, the injection of dsMISS induced a disappearance
of MISS endogenous protein in MII oocytes (Fig. 7, compare E
and F). Moreover, this phenotype was highly reproducible, as it
was observed in 
 
 
 
90% of the 96 asMISS- or dsMISS-injected
oocytes (Fig. 7 E). Interestingly, this phenotype is similar to the
one observed in mos
 
 
 
/
 
 
 
 oocytes, which arrest in metaphase III
(MIII) with monopolar spindles after second polar body extru-
sion (Fig. 8 F; Verlhac et al., 1996).
To prove that the spindle phenotype we observed was spe-
cific, we then microinjected morpholino oligonucleotides di-
rected against 25 bp upstream of the first ATG (Summerton
and Weller, 1997). Again we observed the same phenotype af-
ter injection of morpholino directed against MISS endoge-
nous mRNA (Fig. 8 C), but not after injection of the same
morpholino presenting five mismatches, as recommended by
the manufacturer (Fig. 8 A). The spindle defects observed af-
ter injection of the morpholino oligonucleotide were repro-
ducible and were observed in 63% of the cases (Fig. 8 G). We
could further show that these defects were specific by rescuing
them with an RNA encoding Myc–MISS, which does not
contain the 5
 
 
 
 UTR sequence and is therefore not targeted by
the morpholino. The same oocytes were first injected with
control morpholino or anti-MISS morpholino, and then were
injected with Myc–MISS-encoding RNA. As shown in Fig. 8,
B and D, the injection of Myc–MISS alone or the coinjection
of the control morpholino together with Myc–MISS had no
effect on spindle organization. However, the injection of
Myc–MISS restored normal MII spindle organization (Fig. 8,
Figure 7. Depletion of MISS mRNA 
induces severe spindle defects in MII-
arrested oocytes. Immature oocytes 
were microinjected with asRNA (asMISS) 
or dsRNA (dsMISS or dsFz) directed 
against MISS or Xenopus frizzled mRNA, 
collected 14 h after GVBD, fixed, and 
analyzed by confocal microscopy. For 
each oocyte, the projection of all confocal 
sections was performed. (A) Noninjected 
oocyte (NI) arrested in MII. (B) Oocyte 
injected with asMISS. (C) Oocyte injected 
with dsFz (control). (D) Oocyte injected 
with dsMISS. Microtubules appear in 
green. (E and F) Oocytes stained with 
the anti-MISS peptide antibody. (E) Non-
injected oocyte in MII. (F) Oocyte injected 
with dsMISS. For all images, chromosomes 
appear in red. Bar, 10  m. (G) Statistics of 
the experiment described above. Percent 
MII, percentage of oocytes presenting a 
normal bipolar MII spindle; % spindle 
defects, percentage of oocytes showing 
monopolar spindle, no spindle, and 
numerous asters in the cytoplasm. The 
numbers in brackets correspond to the 
total number of oocytes analyzed. 
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E and G). The coinjection of anti-MISS morpholino with
Myc–MISS RNA induced 
 
 
 
2.5 times less oocytes with MII
spindle defects than injection of the anti-MISS morpholino
alone. MII spindle destabilization in the treated oocytes was
not due to cyclin B1 degradation or global drop in histone H1
kinase activity, as shown in Fig. 8 H.
The fact that we observed the same phenotype using three
different types of molecules directed against endogenous
MISS mRNA, and not with control molecules, is a strong ar-
gument in favor of the specificity of the observed spindle de-
fects. This is further demonstrated by the rescue experiment
using Myc–MISS RNA in morpholino-injected oocytes.
Altogether our results using three different approaches
demonstrate that MISS maintains a bipolar MII spindle
during the CSF arrest of mouse oocytes.
 
MISS does not induce mitotic spindle destabilization
in early embryos
 
Considering the severe phenotypes observed on MII spindles,
we can assume that if such spindle defects are observed after in-
jection of dsMISS into early embryos, they should block cell cy-
cle progression. Indeed, similar defects are observed in mos
 
 
 
/
 
 
 
oocytes (Fig. 8 F) and induce an MIII arrest. To test this hy-
pothesis and therefore see whether MISS also stabilizes mitotic
spindles, we microinjected dsMISS into either zygotes or two
cell embryos and checked whether cell cycle progression was in-
hibited. The injection of dsMISS into zygotes does not block
the division from the one to two cell stage: 99% (
 
n
 
 
 
 
 
 38) of ds-
MISS-injected zygotes undergo the one to two cell division like
the control (
 
n
 
 
 
  
 
36) dsFz-injected ones. Also, dsMISS injection
does not block the two to four cell division: 79% (
 
n
 
 
 
  
 
68) of
dsMISS-injected two cell blastomeres divided to four cell blas-
tomeres, comparable to 81% (
 
n
 
 
 
  
 
70) of dsFz-injected blas-
tomeres. We checked that our dsMISS were indeed efficient by
coinjecting them together with MISS–GFP RNA (Fig. 9). As
for zygotes in interphase (Fig. 4 C), the MISS–GFP protein ac-
cumulated in the nuclei of the injected blastomeres (Fig. 9 B).
However, the MISS–GFP accumulation was very weak when
coinjected with dsMISS, compared with its coinjection with
dsFz (Fig. 9, B and D). We confirmed this by immunoblotting
with an anti-GFP antibody (Fig. 9 E). The MISS–GFP protein
accumulated in dsFz- but not in dsMISS-injected blastomeres.
These experiments demonstrate the specificity and high ef-
ficiency of our dsMISS; it can almost completely abolish ex-
pression of a protein from an abundant exogenous and nor-
mally overexpressed RNA. These experiments are consistent
Figure 8. Myc–MISS rescues the 
depletion of endogenous MISS mRNA 
after morpholino injection. Immature 
oocytes were microinjected, collected 
14 h after GVBD, fixed, and analyzed by 
confocal microscopy. For each oocyte, 
the projection of all confocal sections 
was performed. (A) Oocyte injected with 
MISS morpholino containing five 
mismatches (Cont Mo) as a control. 
(B) Oocyte injected with Myc–MISS 
RNA (MISS). (C) Oocyte injected with 
MISS morpholino (MISS Mo). (D) Oocyte 
coinjected with both control morpholino 
and Myc–MISS RNA (Cont Mo MISS). 
(E) Oocyte coinjected with both MISS 
morpholino and Myc–MISS RNA (MISS 
Mo MISS). (F) Noninjected (NI) mos
 /  
oocyte arrested in MIII with a monopolar 
spindle. Microtubules appear in green 
and chromosomes in red. Bar, 10  m. 
(G) Statistics of the experiment described 
above. Percent MII, percentage of oocytes 
presenting a normal bipolar MII spindle; 
% spindle defects, percentage of oocytes 
showing monopolar spindle, no spindle, 
and numerous asters in the cytoplasm. 
The numbers in brackets correspond to 
the total number of oocytes analyzed. 
(H) Histone H1 kinase activity and 
amount of cyclin B1 in treated oocytes. 
Oocytes either noninjected (NI; lane 1) 
or injected with dsMISS (lane 2) or dsFz 
(lane 3) were collected 12 h after GVBD 
and analyzed for histone H1 kinase 
activity (top) and amount of cyclin B1 
(bottom). 
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with the lack of endogenous MISS staining observed in early
mouse embryos and suggest that MISS does not regulate early
mitotic divisions.
 
Discussion
 
Construction of the cDNA library and isolation of MISS
 
When we started this project, two two-hybrid screens had
been performed using MAPK as a bait (Cook et al., 1996;
Waskiewicz et al., 1997). However, no screen had been per-
formed with a mammalian library prepared from synchro-
nized cells where MAPK is known to play an important role.
We therefore chose mouse immature oocytes for construc-
tion of our cDNA library. These oocytes do not contain
mRNA involved in the support of the whole development,
as is the case for 
 
Xenopus
 
 oocytes, but they present only
mRNA essential for supporting meiotic maturation as well
as the first zygotic division. Despite the low amount of RNA
present in a mouse oocyte (
 
 
 
1 pg of polyA per oocyte), we
were able to construct a cDNA library. To our knowledge
our cDNA library is the sole library of this kind available. It
provides an opportunity for the functional screening and
discovery of mouse genes involved in meiotic maturation as
well as early development.
From the screen performed using ERK2 as bait, we iso-
lated a novel protein, MISS, to which, except for a potential
human homologue, we cannot find any obvious homologues
in the databases. MISS is very rich in proline residues in its
NH
 
2
 
-terminal end and has four potential ERK2 phosphory-
lation sites, a perfect PEST sequence, and a bipartite NLS
that contains a potential MAPK docking site. We confirmed
biochemically the two-hybrid interaction by showing that
MISS coimmunoprecipitates with endogenous MAPK.
We show by RT-PCR that the mRNA is present in imma-
ture oocytes as well as early mouse embryos. We also show
by immunoblotting and immunofluorescence using an af-
finity-purified antipeptide antibody that MISS protein is
present in mouse mature oocytes.
 
MISS is stabilized only in MII and is phosphorylated by 
the Mos/…/MAPK pathway
 
Both by immunoblotting and immunofluorescence, we show
that although the mRNAs are present in immature oocytes,
MISS protein is absent from these oocytes. The endogenous
protein starts to accumulate late in MI, around the first
polar body extrusion. RNA encoding MISS, fused either
to a Myc epitope in an NH
 
2
 
-terminal position or to a GFP
epitope in a COOH-terminal position, cannot induce MISS
accumulation in GV or early MI oocytes, whereas RNA en-
coding Myc–ERK2 is typically associated with similar accu-
mulation of Myc–ERK2 in GV and MII oocytes. Moreover,
treatment of injected oocytes with nocodazole induces accu-
mulation of the protein in MI, where it normally does not
accumulate. Altogether, these data show that MISS is unsta-
ble in MI. The stabilization of the protein occurs in MII, af-
ter the first polar body extrusion. After parthenogenetic acti-
vation, the Myc–MISS protein does not accumulate and is,
therefore, probably degraded. This observation is consistent
with the fact that we cannot detect endogenous MISS in
early embryos by immunofluorescence. The regulation of
MISS stability during meiosis is in agreement with the pres-
ence of a true PEST sequence in the protein.
The activity that is involved in MISS degradation during
MI and disappears in MII does not depend on the Mos/…/
MAPK pathway because Myc–MISS also accumulates in
mos
 
 
 
/
 
 
 
 oocytes.
From studies in 
 
Xenopus
 
 oocytes, we know that MISS is
phosphorylated by active MAPK in vitro (unpublished
data), and we show that in vivo, MISS is partly phosphory-
lated by the Mos/…/MAPK pathway. First, we show that
MISS is hyperphosphorylated in MII oocytes. Indeed, both
endogenous and Myc-tagged MISS migrate at an apparent
molecular weight much higher than the calculated one (45
instead of 29 kD), suggesting the presence of posttransla-
tional modifications. Second, Myc–MISS protein migrates
as discrete spots in 2D gel electrophoresis, which suggests
different phosphorylation states. Third, treatment of Myc–
MISS from MII oocytes with 
 
 
 
-phosphatase induces a severe
downshift of the protein. Eventually, we show by 1D and
Figure 9. Injection of dsMISS does not block early mitotic divisions. 
Late two cell embryos were coinjected into one blastomere either 
with dsRNA against Xenopus frizzled 7 (dsFz; A and B) or dsRNA 
against MISS (dsMISS; C and D) together with the MISS–GFP RNA, 
and were collected after one division. Live embryos were first 
observed using a video microscope equipped with a CCD camera 
(transmitted light on the left; GFP staining on the right), and then 
embryos were analyzed by immunoblotting using an anti-GFP (top) 
and an anti-ERK (bottom) antibody (E). The anti-ERK immunoblot 
serves as a loading control. 
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2D electrophoresis that Myc–MISS is in part phosphory-
lated by the Mos/…/MAPK pathway.
As MISS is stable only in MII, it is reasonable to assume
that the protein is regulated in two steps: (1) stabilization,
which is independent of the Mos/…/MAPK pathway but
might depend on phosphorylation events by other kinases,
and, most likely, (2) full activation through phosphorylation
by the Mos/…/MAPK pathway. This implies that the pro-
tein is mainly active in MII, when CSF activity is present
(Masui and Markert, 1971).
 
MISS is localized in dots on the MII spindles and 
disappears after fertilization
 
The endogenous MISS accumulates in dots on the MII spin-
dles. Also, a MISS–GFP fusion protein shows a strong local-
ization of the protein as bigger patches along fibers that
evoke kinetochore microtubules of the MII spindles. In in-
terphase, although we cannot detect the endogenous MISS
protein, the MISS–GFP protein concentrates into dots in-
side the nucleus and is excluded from the cytoplasm. This
suggests that the NLS present in the protein is functional.
We cannot explain why the MISS–GFP protein accumu-
lates in early embryos when the endogenous protein does
not. One explanation could be that the activity that degrades
MISS in GV, early MI, and activated oocytes is no longer
present in early embryos, and therefore allows accumulation
of an exogenous MISS–GFP protein, whereas it does not al-
low its accumulation in GV or early MI oocytes. This would
imply that a mechanism specific to meiotic maturation con-
trols MISS stability, and this mechanism disappears in early
embryos. Alternatively, MISS could undergo other post-
translational modifications during early development that
prevent its recognition by the antipeptide antibody.
Nonetheless, we believe that MISS is no longer synthe-
sized during early development. First, we showed that Myc–
MISS, which behaves like endogenous MISS and can res-
cue the depletion of the endogenous protein, is no longer
accumulated after parthenogenetic activation. Second, we
showed that dsMISS has no effect on the first two mitotic
divisions, although we demonstrated its activity on abun-
dant exogenous MISS–GFP RNA.
 
MISS is involved in MII spindle stability during the CSF 
arrest of mouse oocytes
 
The localization of MISS and MISS–GFP to MII spindles is
consistent with the phenotypes obtained after asRNA, dsRNA,
and morpholino injection. Indeed, interfering with the endog-
enous mRNA by three different means induces severe spindle
defects only in MII oocytes, where the protein is present, sta-
ble, and probably active. Moreover, we show that the pheno-
type is associated with a lack of accumulation of endogenous
MISS protein in MII. Oocytes that do not possess MISS pro-
tein show disorganized spindles often lacking one pole, or have
long microtubules emanating from both poles and numerous
cytoplasmic asters, which are likely nucleated by cytoplasmic
microtubule organizing centers (Maro et al., 1985). The phe-
notype is specific, because it is rescued by reintroducing Myc–
MISS-encoding RNA into anti-MISS morpholino–injected
oocytes. This phenotype is also very consistent with the micro-
 
tubule defects observed in mos
 
 
 
/
 
 
 
 oocytes and with the local-
ization of MAPK at spindle poles of mouse oocytes (Verlhac et
al., 1994, 1996). The fact that mos
 
 
 
/
 
 
 
 oocytes present some
spindle defects could be due to MISS, which is not fully phos-
phorylated in this strain and probably not active.
Our results suggest that MISS is a spindle-associated pro-
tein that is involved in the stabilization of the MII spindle
during the CSF arrest. As mentioned in the introduction, it
is puzzling that although the Mos/…/MAPK cascade is ac-
tive in MI, it does not induce CSF arrest in MI. MISS could
be an important target of the MAPK cascade that is only sta-
ble in MII (Fig. 10). Because we do not observe a significant
drop in histone H1 kinase activity as well as a degradation of
cyclin B1 in oocytes treated with dsMISS, we think that
MISS plays a role in controlling microtubule dynamics,
through an interaction with a microtubule associated pro-
tein, rather than a direct role in CSF arrest (Fig. 10).
The discovery of this new protein brings some very impor-
tant insights concerning the CSF arrest in vertebrate oo-
cytes: some substrate(s) of the Mos/…/MAPK pathway is
only stable during MII and the Mos/…/MAPK pathway
acts not only on the stabilization of maturation-promoting
factor (MPF) activity but also on spindle stability. It will be
interesting to analyze the relationships between MII spindle
stability and CSF arrest.
 
Materials and methods
 
Collection and culture of mouse oocytes
Immature oocytes arrested at prophase I of meiosis were obtained by remov-
ing ovaries from 11-week-old OF1(WT) and mos
 /  female mice. Oocytes
were removed and cultured as previously described (Verlhac et al., 1996).
Immunofluorescence was performed as previously described (Polanski et al.,
1998). Nocodazole was diluted in the culture medium at 10  M. Activation
by ethanol was performed as previously described (Kubiak, 1989).
Preparation of the mouse oocyte cDNA expression library
Immature oocytes were removed as previously described (Verlhac et al.,
1996), collected in sterile PBS, frozen immediately in dry ice, and stored at
 80 C. Samples corresponding to 1,200 oocytes were lysed by freezing
and thawing. RNA was prepared using the Rneasy Mini Kit (QIAGEN). The
genomic DNA was digested by adding 2 U of RQ1 Dnase (Promega) and
treating with 40 U of RNase inhibitor (Promega). The RNA was precipi-
Figure 10. Proposed model for the role of MISS during mouse 
meiotic maturation. See text for details.612 The Journal of Cell Biology | Volume 157, Number 4, 2002
tated with ethanol and resuspended in water treated with 0.1% diethyl-
pyrocarbonate (H2O-DEPC). Double-stranded cDNA was synthesized from
RNA using a commercial cDNA synthesis kit (SMART PCR cDNA Synthe-
sis Kit; CLONTECH Laboratories, Inc.), as recommended by the manufac-
turer, and using 5 -AAGCAGTGGTAACAACGCAGAGTGAATTCGCGGG
and 5 -GAGAGAGAGAGAGAGAGAGAACTAGTCTCGAG(T)18 primers
for the first strand cDNA synthesis. PCR amplification was performed as
described in the cDNA synthesis kit using 5 -AAGCAGTGGTAACAACG-
CAGAGTGAATTCGCGGG and 5 -GAGAGAGAGAGAGAGAGAGAAC-
TAGTCTCGAGTT primers. The cDNAs between 500 pb and 1 kb were gel
purified and cloned into pYESTrp (Invitrogen) at EcoRI and XhoI sites. We
estimated that the cDNA library consisted of  3   10
6 transformants.
Two-hybrid screen
A two-hybrid screen was performed using the Hybrid Hunter Kit (Invitro-
gen). The bait constructs were generated by PCR amplification from plexA-
ERK2WT and plexA-ERK2KD (Waskiewicz et al., 1997) using 5 -TGAC-
TAGGATCCGTATGGCGGCGGCGGCG and 5 -TGCATCGAGTTAAG-
ATCTGTATCCTGG primers and cloned as a BamH1/XhoI fragment into
pEG202. plexA-Su(Fu) (mouse suppressor of fused) was a gift of A. Plessis
(Institut Jacques Monod, Paris, France). We thank J. Cooper for the gift of
the pLexA-ERKWT and plexA-ERKKD plasmids.
The pEG202-lexA-ERK2WT construct was introduced into the yeast
EGY48 (MAT  ura3 trp1 his3 6lexAop-LEU2) strain transformed with
pSH18-34. pEG202-lexA-ERK2WT was tested for spontaneous activation
of the LEU2 and lacZ reporter genes. The EGY48 strain transformed with
pEG202-lexA-ERK2WT and pSH18-34 was further transformed with the
cDNA library cloned into pYESTrp. We screened 4   10
6 transformants.
The two-hybrid tests of specificity were performed using different baits
in the strain RFY206 mated with the strain EGY48 containing the potential
positive clones.
RT-PCR assay
RT-PCR was processed as previously described (Ledan et al., 2001). PCR
amplification was performed using 5 -ATGTATCCCTTCATCCCTCCA and
5 -TCATTTAGACCCTTCACTTTC primers.
Plasmid construction and in vitro synthesis of RNA
pRN3Myc–MISS was constructed by RT-PCR amplification from mouse ova-
ries. Total RNA was extracted using the Rneasy Mini Kit (QIAGEN). The re-
verse transcription was performed on 500 ng of RNA. The PCR amplification
was done on 50 ng of RNA/DNA using 5 -ATGCGAATTCAGAATGTATC-
CCTTCATCCCT and 5 -ATGCGCGGCCGCTTAAATTAAACTGTTTATTA
primers. The 814-bp PCR product was then cloned into pRN3Myc2.
pRN3MISSGFP was obtained by PCR subcloning at XhoI/EcoRI sites using
5 -ATGCCTCGAGATGTATCCCTTCATCCCTCC and 5 -ATGCGAATTC-
CTTTAGACCCTTCACTTTCA primers. The in vitro synthesis of capped RNA
was performed as previously described (Verlhac et al., 2000b).
Microinjection
Microinjection of in vitro–transcribed RNA was performed as previously
described (Verlhac et al., 2000b). The sequence of the control morpholino
oligonucleotide is 5 -CATACTTCTTGCTGCTGCCCCGTAG and the se-
quence of the anti-Miss morpholino oligonucleotide is 5 -CATTCTTGTTG-
GTGCTGCTCCGAAG.
Coimmunoprecipitation in Xenopus oocyte extracts
Xenopus oocyte microinjection as well as extraction were performed as previ-
ously described (Gavin et al., 1999). For the immunoprecipitation of xp42
mpk1,
we used an anti-ERK2 antibody conjugated to agarose (Santa Cruz Biotechnol-
ogy, Inc.). Xenopus oocyte extracts (300  l) were precleared with 20  l of pro-
tein A coupled to agarose beads for 30 min at 4 C. The cleared extracts were
then incubated for 2 h at 4 C with the antibody coupled to agarose beads. The
beads were washed four times in lysis buffer supplemented with 150 mM
NaCl and then processed for immunoblotting.
Dephosphorylation assay
Just after collection and lysis, oocytes were incubated with or without
400 U of  -phosphatase (New England BioLabs, Inc.) in  -phosphatase
buffer at 37 C for 1 h and then processed for immunoblotting.
2D gel electrophoresis
Oocytes were stored at  80 C in water containing 1  M okadaic acid (LC
Laboratories) and 80  M  -glycerophosphate. They were then processed
as previously described (Louvet-Vallee et al., 2001).
Immunoblotting
Oocytes at the appropriate stage of maturation were collected in sample
buffer (Laemmli, 1970) and heated for 3 min at 100 C. We used the fol-
lowing antibodies: an affinity-purified anti-MISS antibody directed against
the peptide TMLHVNSQHESEGSK; the 9E10 monoclonal antibody (sc-40;
Santa Cruz Biotechnology, Inc.) for Myc-tagged MISS; the monoclonal an-
tibody (no. 1814460, Boehringer) against GFP-tagged MISS; the mono-
clonal antibody (no. M3530; Dako) against cyclin B1; and the anti-ERK an-
tibody (sc-94; Santa Cruz Biotechnology, Inc.).
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